Nevro (NYSE:NVRO) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.76) by 46.05 percent. This is a 36.92 percent increase over losses of $(0.65) per share from the same period last year. The company reported quarterly sales of $96.91 million which beat the analyst consensus estimate of $93.07 million by 4.13 percent. This is a 6.69 percent decrease over sales of $103.86 million the same period last year.